BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33127570)

  • 1. Clinical and Hemodynamic Features in Moyamoya Disease with Intracranial Aneurysms.
    Sun H; Tian R; Yu Z; Xiao A; You C; Liu Y
    World Neurosurg; 2021 Feb; 146():e509-e516. PubMed ID: 33127570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of aneurysms in patients with moyamoya disease: a 10-year single-center experience.
    Ni W; Jiang H; Xu B; Lei Y; Yang H; Su J; Gu Y; Mao Y
    J Neurosurg; 2018 Jun; 128(6):1813-1822. PubMed ID: 28841118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracranial Aneurysms in White Patients with Moyamoya Disease: A U.S. Single-Center Case Series and Review.
    Larson A; Rinaldo L; Brinjikji W; Meyer F; Lanzino G
    World Neurosurg; 2020 Jun; 138():e749-e758. PubMed ID: 32201292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment strategies of ruptured intracranial aneurysms associated with moyamoya disease.
    Zhao X; Wang X; Wang M; Meng Q; Wang C
    Br J Neurosurg; 2021 Apr; 35(2):209-215. PubMed ID: 32567379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prospects and pitfalls in the endovascular treatment of moyamoya disease-associated intracranial aneurysms.
    Hou K; Li G; Luan T; Xu K; Yu J
    Neurosurg Rev; 2021 Feb; 44(1):261-271. PubMed ID: 32052219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracranial Aneurysms in Adult Moyamoya Disease.
    Kim JH; Kwon TH; Kim JH; Chong K; Yoon W
    World Neurosurg; 2018 Jan; 109():e175-e182. PubMed ID: 28962951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Location-based treatment of intracranial aneurysms in moyamoya disease: a systematic review and descriptive analysis.
    Larson AS; Rinaldo L; Brinjikji W; Lanzino G
    Neurosurg Rev; 2021 Apr; 44(2):1127-1139. PubMed ID: 32385590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of and risk factors for intracranial aneurysms associated with moyamoya disease.
    Yang H; Zhang L; Wang M; Wang J; Chen L; Lu H
    Int J Stroke; 2021 Jul; 16(5):542-550. PubMed ID: 33176625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and prognostic analysis of moyamoya disease associated with intracranial aneurysms.
    Yan J; Lv M; Zeng E; Tang B; Xie S; Hong T
    Neurol Res; 2020 Sep; 42(9):767-772. PubMed ID: 32567530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidental major artery aneurysms in patients with non-hemorrhagic moyamoya disease.
    Yeon JY; Kim JS; Hong SC
    Acta Neurochir (Wien); 2011 Jun; 153(6):1263-70. PubMed ID: 21279660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance of Intracranial Aneurysms in Adult Moyamoya Disease.
    Myeong HS; Kim K; Lee SH; Yoo DH; Cho YD; Cho WS; Kang HS; Kim JE
    World Neurosurg; 2022 Aug; 164():e1034-e1042. PubMed ID: 35643409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategies for aneurysms associated with moyamoya disease.
    Zhang L; Xu K; Zhang Y; Wang X; Yu J
    Int J Med Sci; 2015; 12(3):234-42. PubMed ID: 25678840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of ruptured aneurysms of the choroidal collateral system in moyamoya disease: a systematic review and data analysis.
    Wiedmann MKH; Davidoff C; Lo Presti A; Ni W; Rhim JK; Simons M; Stoodley MA
    J Neurosurg; 2022 Mar; 136(3):637-646. PubMed ID: 34450582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features, surgical treatment, and outcome of intracranial aneurysms associated with moyamoya disease.
    Ge P; Ye X; Zhang Q; Liu X; Deng X; Zhao M; Wang J; Wang R; Zhang Y; Zhang D; Zhao J
    J Clin Neurosci; 2020 Oct; 80():274-279. PubMed ID: 33099360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of rupture and mortality for intracranial aneurysms associated with moyamoya disease: a multicenter retrospective study.
    Zhang H; Lu W; Liang J; Wang H; Zhao Y; Yang X; Feng L; Li M
    Neurol Sci; 2024 May; 45(5):2137-2147. PubMed ID: 38032535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification and treatment strategy for Moyamoya disease-related aneurysms.
    Hu Y; Wang X; Li C; Zhao L; Luo J; Ye L; Cheng B
    Chin Neurosurg J; 2023 Dec; 9(1):37. PubMed ID: 38124096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural course and risk factors of moyamoya disease with unruptured intracranial aneurysm.
    Yang RM; Hao FB; Zhao B; Zhang Q; Yu D; Zou ZX; Gao G; Guo QB; Shen XX; Fu HG; Liu SM; Wang MJ; Li JJ; Han C
    Front Neurol; 2023; 14():1115909. PubMed ID: 36846147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic characteristics and mechanism for intracranial aneurysms initiation with the circle of Willis anomaly.
    Zheng R; Han Q; Hong W; Yi X; He B; Liu Y
    Comput Methods Biomech Biomed Engin; 2024 May; 27(6):727-735. PubMed ID: 37078775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiographic and Hemodynamic Features in Asymptomatic Hemispheres of Patients With Moyamoya Disease.
    Sun H; Li W; Xia C; Ren Y; Ma L; Xiao A; You C; Liu Y; Tian R
    Stroke; 2022 Jan; 53(1):210-217. PubMed ID: 34547926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruptured Aneurysms of Collateral Vessels in Adult Onset Moyamoya Disease with Hemorrhagic Presentation.
    Rhim JK; Cho YD; Jeon JP; Yoo DH; Cho WS; Kang HS; Kim JE; Han MH
    Clin Neuroradiol; 2018 Jun; 28(2):191-199. PubMed ID: 27966197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.